Shengbang Wang

Shengbang Wang

Auto-generated profile, based on publicly available information

Shengbang Wang

Department of Dermatology the First Affiliated Hospital of Xi'an Jiaotong University Xi'an China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YHYingjian Huang
Yingjian Huang
YWYuqian Wang
Yuqian Wang
YWYan Wang
Yan Wang
NWNing Wang
Ning Wang
QDQiqi Duan
Qiqi Duan
Yan ZhengYan Zheng
Yan Zheng

13 September 2017 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
FJFanpu Ji
Fanpu Ji
Wenjun WangWenjun Wang
Wenjun Wang
SDShuangsuo Dang
Shuangsuo Dang
SWShengbang Wang
Shengbang Wang
BLBurong Li
Burong Li
ZLZongfang Li
Zongfang Li
Direct-acting antivirals have been used for decompensated cirrhotic patients with hepatitis C virus (HCV) infection. However, the benefits in Chinese patients with decompensated cirrhosis are unclear. Thirty patients with HCV infection and decompensated cirrhosis were administered sofosbuvir-containing regimens at our hospital between April and December 2015. The efficacy and safety of the treatments was determined by sustained virological response at week 12 (SVR 12), change of liver function and adverse events. The cohort included 13 treatment-experienced and 17 treatment-naïve patients. A total of 27 patients (90%) achieved SVR 12. No baseline characteristics (sex, age, treatment-experience, genotype, viral load, liver function or splenectomy) was association with achievement of SVR 12. Patients achieved SVR 12 had significantly improved liver function by post-treatment week 12 (P < 0.05). Of the 30 patients, six developed anemia, one developed hepatic decompensation, two developed impaired renal function and one developed a severe upper respiratory tract infection during the treatment. There was no death or HCC development during 12 months of follow-up off-therapy. Two patients (7.4%) with SVR 12 experienced new decompensated episodes during the follow-up. Sofosbuvir-containing regimens are effective in Chinese HCV patients with decompensated cirrhosis, regardless of baseline characteristics, as demonstrated by a high rate of SVR 12, as well as improvement in liver function. Although antiviral therapy is generally well tolerated, a vigilant monitoring of anemia and renal function should be mandatory.

10 January 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
TKTong Kang
Tong Kang
CZCheng Zhang
Cheng Zhang
HLHao Lei
Hao Lei
RLRuiting Luo
Ruiting Luo
MLMeng Liu
Meng Liu
Yan ZhengYan Zheng
Yan Zheng

6 September 2022 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
XZXiu Zhang
Xiu Zhang
SWShengbang Wang
Shengbang Wang
WWWei Wang
Wei Wang
LSLiumei Song
Liumei Song
SFShuo Feng
Shuo Feng
Yan ZhengYan Zheng
Yan Zheng
Psoriasis is a chronic inflammatory skin disease, and elevation of proinflammatory cytokine levels is a critical driver of the pathogenesis of psoriasis. Extracellular cold-inducible RNA-binding protein (eCIRP) has been shown to play a role in various acute and chronic inflammatory diseases. C23, a short peptide derived from CIRP, competitively binds CIRP receptors and reduces damage in inflammatory diseases. However, the effect of eCIRP in psoriasis has not been studied. In the present study, we investigated the role of eCIRP in the expression of proinflammatory cytokines in keratinocytes. Our data show that eCIRP expression was increased in the sera of psoriasis patients and imiquimod- (IMQ-) induced psoriatic mice and cells stimulated with proinflammatory cytokines (IL-1α, IL-17A, IL-22, oncostatin M, and TNF-α; mix M5). Recombinant human CIRP (rhCIRP) promoted the expression of the proinflammatory cytokines TNF-α, IL-6, and IL-8 and the activation of NF-kappaB (NF-κB) and ERK1/2 in cultured keratinocytes. We then found that the above effects of eCIRP could be blocked by C23 in both normal keratinocytes and M5-stimulated psoriatic keratinocytes. In addition, in vivo experiments revealed that C23 could effectively ameliorate IMQ-induced psoriatic dermatitis. TNF-α and IL-6 mRNA expressions were reduced in the skin lesions of mice with C23-treated IMQ-induced psoriasis, and this effect was accompanied by inhibition of the NF-κB and ERK1/2 signaling pathways. In summary, eCIRP plays an important role in the pathogenesis of psoriasis and may become a new target for psoriasis treatment.

15 May 2017 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
FJFanpu Ji
Fanpu Ji
WZWenxuan Zhao
Wenxuan Zhao
LHLiu Hailing
Liu Hailing
HZHongbo Zheng
Hongbo Zheng
SWShengbang Wang
Shengbang Wang
HDHong Deng
Hong Deng

2 February 2023 in Molecular Carcinogenesis
Verified
Journal Article
Closed access
SWShengbang Wang
Shengbang Wang
XZXiu Zhang
Xiu Zhang
HLHao Lei
Hao Lei
LSLiumei Song
Liumei Song
YHYingjian Huang
Yingjian Huang
Yan ZhengYan Zheng
Yan Zheng